Table 2.
Female patients (n = 63) | Female subjects of control group (n = 54) | P | Male patients (n = 14) | Male subjects of control group (n = 26) | P | |
---|---|---|---|---|---|---|
ASCA IgG or IgA | 19% (12 /63) | 5.5% (3/54) | 0.05 | 7.1% (1/14) | 0% | NS |
ASCA IgG and IgA | 7.9% (5/63) | 0% | 0.04 | 0% | 0% | NS |
ASCA IgG | 17.5% (11/63) | 3.7% (2/54) | 0.03 | 7.1% (1/14) | 3.8% (1/26) | NS |
ASCA IgA | 9.5% (6/63) | 1.8% (1/54) | NS | 0% | 3.8% (1/26) | NS |
ASCA, anti Saccharomyces cerevisiae antibodies; NS, not significant.